JCCC Research Seminar featuring Roger Slavik
The Ahmanson Biomedical Cyclotron Facility and its role in optimizing targeted radioligand therapy
- Date: May 16, 2019 12:00 PM - 1:00 PM
- Location: 53-105 CHS
10833 Le Conte Ave.
Los Angeles, California 90095
Roger Slavik, Ph.D.
Assistant Professor, Molecular and Medical Pharmacology Director, Ahmanson Biomedical Cyclotron Facility
Dr. Roger Salvik’s research focuses on the development of theranostics for the diagnosis and treatment of cancer and the synthesis of novel potential PET probes for use as cancer biomarkers. He is the director of the Ahmanson Biomedical Cyclotron Facility, which manufactures a variety of PET ligands for clinical service and synthesizes probes for clinical and preclinical research.
Light lunch served
Sponsored by the UCLA Jonsson Comprehensive Cancer Center Cancer Molecular Imaging, Nanotechnology and Theranostics Program